The Board Members and Co-Founders at OMEICOS Therapeutics provide strategic oversight, ensure robust governance, and guide the company's vision in developing novel molecules for the treatment and prevention of atrial fibrillation. They leverage their expertise to drive innovation, secure funding, and make key decisions that shape the company's growth and scientific direction.
View all